Angion
Angion is committed to transforming the treatment paradigm for patients suffering from fibrotic diseases.
19 employees · est. 1998 · United States
C4 Therapeutics, Inc.
Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science
111 employees · est. 2015 · Watertown, United States
Angion is the older company (1998 vs 2015); C4 Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Angion | C4 Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 1998 older | 2015 |
| Headquarters | ||
| Headquarters | United States | Watertown, United States |
| Employees | ||
| Employees | 19 | 111 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $84.27M | $218.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 5 |
| Services | ||
| Services | Not tracked yet | Drug Discovery, Clinical Research, Partner Collaborations, Scientific Publications |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients and Families, Healthcare Providers, Investors, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Drug Discovery, Organ Restoration, Renal Disease, Fibrotic Diseases, Acute Organ Injuries, Small Molecule Therapeutics, Clinical-stage, Delayed Graft Function, Acute Kidney Injury, Cardiopulmonary Bypass, Phase 3, Phase 2, Late-stage, Patient Treatment Paradigm | Protein Degradation, Targeted Protein Degradation Science, Oncology Programs, TORPEDO® Platform, Small-Molecule Medicines, Drug Resistance Overcoming, Degronimids, Ubiquitin/Proteasome System, Biopharmaceuticals, Synthetic Chemical Compounds, Targeted Therapeutics, Cell Biology, Protein Chemistry, Cell Pharmacology, Dana-Farber Collaboration |
| Website | ||
| Website | angion.com | c4therapeutics.com |
About Angion
Angion is a late-stage biopharmaceutical company committed to transforming the treatment paradigm for patients suffering from fibrotic diseases. Established in 1998 and headquartered in the United States, Angion focuses on the discovery, development, and commercialization of novel small molecule the...
About C4 Therapeutics, Inc.
C4 Therapeutics, Inc. is a clinical-stage biotech company that is revolutionizing the treatment of diseases through targeted protein degradation science. Founded in 2015 and headquartered in the United States, the company focuses on unleashing the potential of its proprietary TORPEDO® platform to de...
We will tell you when either one moves
BounceWatch watches Angion and C4 Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Angion and C4 Therapeutics, Inc. — by email.
Frequently Asked Questions
Compare Angion with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Angion on 12 Sep 2024, and C4 Therapeutics, Inc. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.